Drug General Information (ID: D0182)
  Drug Name
Binimetinib
  Drug Type Small molecule
  Drug Synonymous
606143-89-9; Binimetinib; MEK162; MEK-162; ARRY-438162; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; ARRY 162; UNII-181R97MR71; Binimetinib (MEK162, ARRY-162, ARRY-438162); 181R97MR71; MEK162 (ARRY-162, ARRY-438162); 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; Binimetinib [USAN:INN]; MEK 162; ARRY 438162; MEK162(Binimetinib); Binimetinib (JAN/USAN); D0C4LF; NVP-ME
    Click to Show/Hide
  Disease Class 2C30: Melanoma
  Therapeutic Class Multikinase Inhibitors
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C17H15BrF2N4O3
  InChI 1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
  InChIKey ACWZRVQXLIRSDF-UHFFFAOYSA-N
  Canonical SMILES CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO
  External Link
Pubchem ID 10288191
CAS Number 606143-89-9
CHEBI ID 145371
TTD ID D0C4LF
INTEDE ID DR0214
VARIDT ID DR01336

Drug-Drug Interaction Network
  Sunburst Graph
AM002  Affected cellular transport
AM004  Affected intra/extra-hepatic metabolism
AM006  Pharmacodynamic additive effects
BM010  Transporter inhibition
BM011  Transporter induction
BM019  UGT inhibition
BM022  CYP450 enzyme induction
BM023  UGT induction
BM047  Additive thrombogenic effects
BM050  Increased risk of bleeding
BM055  Increased risk of hepatotoxicity
  Relation Graph
 Full list of drugs interacting with Binimetinib
      Affected cellular transport
   Transporter inhibition Drug Num:  91
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0007
 
Abiraterone
 
C24H31NO
 
132971 
Moderate    Inter Info   
[21], [2], [46]
D0026
 
Afatinib
 
C24H25ClFN5O3
 
10184653 
Moderate    Inter Info   
[21], [2], [46]
D0066
 
Amiodarone
 
C25H29I2NO3
 
2157 
Moderate    Inter Info   
[21], [2], [46]
D0115
 
Astemizole
 
C28H31FN4O
 
2247 
Moderate    Inter Info   
[21], [2], [46]
D0116
 
Atazanavir
 
C38H52N6O7
 
148192 
Moderate    Inter Info   
[21], [2], [46]
D0120
 
Atorvastatin
 
C33H35FN2O5
 
60823 
Moderate    Inter Info   
[21], [2], [46]
D0139
 
Azithromycin
 
C38H72N2O12
 
447043 
Moderate    Inter Info   
[21], [2], [46]
D0170
 
Bepridil
 
C24H34N2O
 
2351 
Moderate    Inter Info   
[21], [2], [46]
D0425
 
Darolutamide
 
C19H19ClN6O2
 
67171867 
Moderate    Inter Info   
[21], [2], [46]
D0555
 
Elagolix
 
C32H30F5N3O5
 
11250647 
Moderate    Inter Info   
[21], [2], [46]
D0696
 
Fosnetupitant
 
C31H35F6N4O5P
 
71544786 
Moderate    Inter Info   
[21], [2], [46]
D0699
 
Fostamatinib
 
C23H26FN6O9P
 
11671467 
Moderate    Inter Info   
[21], [2], [46]
D0726
 
Glecaprevir
 
C38H46F4N6O9S
 
66828839 
Moderate    Inter Info   
[21], [2], [46]
D1432
 
Rucaparib
 
C19H18FN3O
 
9931954 
Moderate    Inter Info   
[21], [2], [46]
D1445
 
Sarecycline
 
C24H29N3O8
 
54681908 
Moderate    Inter Info   
[21], [2], [46]
D1539
 
Tedizolid
 
C17H15FN6O3
 
11234049 
Moderate    Inter Info   
[21], [2], [46]
D1653
 
Troleandomycin
 
C41H67NO15
 
202225 
Moderate    Inter Info   
[21], [2], [46]
D0192
 
Boceprevir
 
C27H45N5O5
 
10324367 
Moderate    Inter Info   
[21], [2], [46]
D0254
 
Captopril
 
C9H15NO3S
 
44093 
Moderate    Inter Info   
[21], [2], [46]
D0349
 
Clarithromycin
 
C38H69NO13
 
84029 
Moderate    Inter Info   
[21], [2], [46]
D0386
 
Conivaptan
 
C32H26N4O2
 
151171 
Moderate    Inter Info   
[21], [2], [46]
D0393
 
Crizotinib
 
C21H22Cl2FN5O
 
11626560 
Moderate    Inter Info   
[21], [2], [46]
D0402
 
Cyclosporine
 
C62H111N11O12
 
5284373 
Moderate    Inter Info   
[21], [2], [46]
D0408
 
Daclatasvir
 
C40H50N8O6
 
25154714 
Moderate    Inter Info   
[21], [2], [46]
D0409
 
Dacomitinib
 
C24H25ClFN5O2
 
11511120 
Moderate    Inter Info   
[21], [2], [46]
D0439
 
Delavirdine
 
C22H28N6O3S
 
5625 
Moderate    Inter Info   
[21], [2], [46]
D0476
 
Diclofenac
 
C14H11Cl2NO2
 
3033 
Moderate    Inter Info   
[21], [2], [46]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Moderate    Inter Info   
[21], [2], [46]
D0534
 
Dronedarone
 
C31H44N2O5S
 
208898 
Moderate    Inter Info   
[21], [2], [46]
D0556
 
Elbasvir
 
C49H55N9O7
 
71661251 
Moderate    Inter Info   
[21], [2], [46]
D0559
 
Eliglustat
 
C23H36N2O4
 
23652731 
Moderate    Inter Info   
[21], [2], [46]
D0561
 
Eltrombopag
 
C25H22N4O4
 
135449332 
Moderate    Inter Info   
[21], [2], [46]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[21], [2], [46]
D0594
 
Eribulin
 
C40H59NO11
 
11354606 
Moderate    Inter Info   
[21], [2], [46]
D0597
 
Erythromycin
 
C37H67NO13
 
12560 
Moderate    Inter Info   
[21], [2], [46]
D0640
 
Felodipine
 
C18H19Cl2NO4
 
3333 
Moderate    Inter Info   
[21], [2], [46]
D0658
 
Fidaxomicin
 
C52H74Cl2O18
 
10034073 
Moderate    Inter Info   
[21], [2], [46]
D0713
 
Gefitinib
 
C22H24ClFN4O3
 
123631 
Moderate    Inter Info   
[21], [2], [46]
D0799
 
Indinavir
 
C36H47N5O4
 
5362440 
Moderate    Inter Info   
[21], [2], [46]
D0852
 
Isavuconazonium
 
C35H35F2N8O5S+
 
6918606 
Moderate    Inter Info   
[21], [2], [46]
D0867
 
Itraconazole
 
C35H38Cl2N8O4
 
55283 
Moderate    Inter Info   
[21], [2], [46]
D0869
 
Ivacaftor
 
C24H28N2O3
 
16220172 
Moderate    Inter Info   
[21], [2], [46]
D0873
 
Ixabepilone
 
C27H42N2O5S
 
6445540 
Moderate    Inter Info   
[21], [2], [46]
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Moderate    Inter Info   
[21], [2], [46]
D0894
 
Lapatinib
 
C29H26ClFN4O4S
 
208908 
Moderate    Inter Info   
[21], [2], [46]
D0898
 
Ledipasvir
 
C49H54F2N8O6
 
67505836 
Moderate    Inter Info   
[21], [2], [46]
D0903
 
Lenvatinib
 
C21H19ClN4O4
 
9823820 
Moderate    Inter Info   
[21], [2], [46]
D0956
 
Lovastatin
 
C24H36O5
 
53232 
Moderate    Inter Info   
[21], [2], [46]
D1017
 
Methadone
 
C21H27NO
 
4095 
Moderate    Inter Info   
[21], [2], [46]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Moderate    Inter Info   
[21], [2], [46]
D1063
 
Mifepristone
 
C29H35NO2
 
55245 
Moderate    Inter Info   
[21], [2], [46]
D1074
 
Mirabegron
 
C21H24N4O2S
 
9865528 
Moderate    Inter Info   
[21], [2], [46]
D1109
 
Naproxen
 
C14H14O3
 
156391 
Moderate    Inter Info   
[21], [2], [46]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Moderate    Inter Info   
[21], [2], [46]
D1124
 
Neratinib
 
C30H29ClN6O3
 
9915743 
Moderate    Inter Info   
[21], [2], [46]
D1127
 
Netupitant
 
C30H32F6N4O
 
6451149 
Moderate    Inter Info   
[21], [2], [46]
D1134
 
Nifedipine
 
C17H18N2O6
 
4485 
Moderate    Inter Info   
[21], [2], [46]
D1140
 
Niraparib
 
C19H20N4O
 
24958200 
Moderate    Inter Info   
[21], [2], [46]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Moderate    Inter Info   
[21], [2], [46]
D1214
 
Palbociclib
 
C24H29N7O2
 
5330286 
Moderate    Inter Info   
[21], [2], [46]
D1315
 
Posaconazole
 
C37H42F2N8O4
 
468595 
Moderate    Inter Info   
[21], [2], [46]
D1348
 
Progesterone
 
C21H30O2
 
5994 
Moderate    Inter Info   
[21], [2], [46]
D1353
 
Propafenone
 
C21H27NO3
 
4932 
Moderate    Inter Info   
[21], [2], [46]
D1371
 
Quinidine
 
C20H24N2O2
 
441074 
Moderate    Inter Info   
[21], [2], [46]
D1372
 
Quinine
 
C20H24N2O2
 
3034034 
Moderate    Inter Info   
[21], [2], [46]
D1383
 
Ranolazine
 
C24H33N3O4
 
56959 
Moderate    Inter Info   
[21], [2], [46]
D1393
 
Reserpine
 
C33H40N2O9
 
5770 
Moderate    Inter Info   
[21], [2], [46]
D1398
 
Ribociclib
 
C23H30N8O
 
44631912 
Moderate    Inter Info   
[21], [2], [46]
D1423
 
Rolapitant
 
C25H26F6N2O2
 
10311306 
Moderate    Inter Info   
[64]
D1437
 
Safinamide
 
C17H19FN2O2
 
131682 
Moderate    Inter Info   
[21], [2], [46]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Moderate    Inter Info   
[21], [2], [46]
D1471
 
Simeprevir
 
C38H47N5O7S2
 
24873435 
Moderate    Inter Info   
[21], [2], [46]
D1473
 
Simvastatin
 
C25H38O5
 
54454 
Moderate    Inter Info   
[21], [2], [46]
D1496
 
Sonidegib
 
C26H26F3N3O3
 
24775005 
Moderate    Inter Info   
[21], [2], [46]
D1497
 
Sorafenib
 
C21H16ClF3N4O3
 
216239 
Moderate    Inter Info   
[21], [2], [46]
D1524
 
Suvorexant
 
C23H23ClN6O2
 
24965990 
Moderate    Inter Info   
[21], [2], [46]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[21], [2], [46]
D1533
 
Tamoxifen
 
C26H29NO
 
2733526 
Moderate    Inter Info   
[21], [2], [46]
D1541
 
Telaprevir
 
C36H53N7O6
 
3010818 
Moderate    Inter Info   
[21], [2], [46]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Moderate    Inter Info   
[21], [2], [46]
D1558
 
Testosterone
 
C19H28O2
 
6013 
Moderate    Inter Info   
[21], [2], [46]
D1579
 
Ticagrelor
 
C23H28F2N6O4S
 
9871419 
Moderate    Inter Info   
[21], [2], [46]
D1608
 
Tolvaptan
 
C26H25ClN2O3
 
216237 
Moderate    Inter Info   
[21], [2], [46]
D1645
 
Trimethoprim
 
C14H18N4O3
 
5578 
Moderate    Inter Info   
[21], [2], [46]
D1664
 
Ulipristal
 
C28H35NO3
 
13559281 
Moderate    Inter Info   
[21], [2], [46]
D1673
 
Valbenazine
 
C24H38N2O4
 
24795069 
Moderate    Inter Info   
[21], [2], [46]
D1677
 
Valproic acid
 
C8H16O2
 
3121 
Moderate    Inter Info   
[21], [2], [46]
D1681
 
Vandetanib
 
C22H24BrFN4O2
 
3081361 
Moderate    Inter Info   
[21], [2], [46]
D1686
 
Velpatasvir
 
C49H54N8O8
 
67683363 
Moderate    Inter Info   
[21], [2], [46]
D1687
 
Vemurafenib
 
C23H18ClF2N3O3S
 
42611257 
Moderate    Inter Info   
[21], [2], [46]
D1690
 
Verapamil
 
C27H38N2O4
 
2520 
Moderate    Inter Info   
[21], [2], [46]
   Transporter induction Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0080
 
Amprenavir
 
C25H35N3O6S
 
65016 
Moderate    Inter Info   
[21], [2], [46], [47]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Moderate    Inter Info   
[21], [2], [46], [47]
D1502
 
St. John's Wort
 
NA
 
NA
Moderate    Inter Info   
[21], [2], [46], [47]
      Affected intra/extra-hepatic metabolism
   UGT inhibition Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0715
 
Gemfibrozil
 
C15H22O3
 
3463 
Moderate    Inter Info   
[21], [2], [46]
D0991
 
Mefenamic acid
 
C15H15NO2
 
4044 
Moderate    Inter Info   
[21], [2], [46]
   CYP450 enzyme induction Drug Num:  12
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0028
 
Albendazole
 
C12H15N3O2S
 
2082 
Moderate    Inter Info   
[21], [2], [46], [47]
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[21], [2], [46], [47]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Moderate    Inter Info   
[21], [2], [46], [47]
D0697
 
Fosphenytoin
 
C16H15N2O6P
 
56339 
Moderate    Inter Info   
[21], [2], [46], [47]
D1081
 
Modafinil
 
C15H15NO2S
 
4236 
Moderate    Inter Info   
[21], [2], [46], [47]
D1179
 
Omeprazole
 
C17H19N3O3S
 
4594 
Moderate    Inter Info   
[21], [2], [46], [47]
D1190
 
Osimertinib
 
C28H33N7O2
 
71496458 
Moderate    Inter Info   
[21], [2], [46], [47]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[21], [2], [46], [47]
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Moderate    Inter Info   
[21], [2], [46], [47]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[21], [2], [46], [47]
D1400
 
Rifampicin
 
C43H58N4O12
 
135398735 
Moderate    Inter Info   
[2], [46], [47]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Moderate    Inter Info   
[21], [2], [46], [47]
   UGT induction Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0601
 
Eslicarbazepine
 
C15H14N2O2
 
9881504 
Moderate    Inter Info   
[21], [2], [46], [47]
      Pharmacodynamic additive effects
   Additive thrombogenic effects Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1569
 
Thalidomide
 
C13H10N2O4
 
5426 
Major    Inter Info   
[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
   Increased risk of bleeding Drug Num:  18
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0008
 
Acalabrutinib
 
C26H23N7O2
 
71226662 
Major    Inter Info   
[1]
D0129
 
Avapritinib
 
C26H27FN10
 
118023034 
Major    Inter Info   
[2], [3]
D0805
 
Inotersen
 
C230H318N69O121P19S19
 
121492004 
Major    Inter Info   
[2], [4], [5]
D1718
 
Zanubrutinib
 
C27H29N5O3
 
135565884 
Major    Inter Info   
[4]
D0230
 
Cabozantinib
 
C28H24FN3O5
 
25102847 
Major    Inter Info   
[7]
D0428
 
Dasatinib
 
C22H26ClN7O2S
 
3062316 
Major    Inter Info   
[8]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Major    Inter Info   
[4], [9]
D0537
 
Drotrecogin alfa
 
NA
 
NA
Major    Inter Info   
[10]
D0784
 
Ibritumomab tiuxetan
 
NA
 
NA
Major    Inter Info   
[11]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Major    Inter Info   
[12], [13], [2], [14]
D1174
 
Omacetaxine mepesuccinate
 
C29H39NO9
 
285033 
Major    Inter Info   
[4], [20]
D1221
 
Panobinostat
 
C21H23N3O2
 
6918837 
Major    Inter Info   
[21], [2], [22]
D1313
 
Ponatinib
 
C29H27F3N6O
 
24826799 
Major    Inter Info   
[23]
D1380
 
Ramucirumab
 
NA
 
NA
Major    Inter Info   
[24]
D1387
 
Regorafenib
 
C21H15ClF4N4O3
 
11167602 
Major    Inter Info   
[2], [25], [26]
D1592
 
Tipranavir
 
C31H33F3N2O5S
 
54682461 
Major    Inter Info   
[43]
D1613
 
Tositumomab
 
NA
 
NA
Major    Inter Info   
[44], [45]
D1614
 
Tositumomab (I-131)
 
NA
 
NA
Major    Inter Info   
[44], [45]
   Increased risk of hepatotoxicity Drug Num:  19
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Major    Inter Info   
[6]
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[15], [16], [17]
D0944
 
Lomitapide
 
C39H37F6N3O2
 
9853053 
Major    Inter Info   
[18]
D1073
 
Mipomersen
 
C230H324N67O122P19S19
 
118984467 
Major    Inter Info   
[19]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[15], [16], [17]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[48]
D1389
 
Remdesivir
 
C27H35N6O8P
 
121304016 
Moderate    Inter Info   
[21], [2], [49], [50], [51]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Moderate    Inter Info   
[52]
D0248
 
Cannabidiol
 
C21H30O2
 
644019 
Moderate    Inter Info   
[2], [53]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[54], [55]
D0584
 
Epirubicin
 
C27H29NO11
 
41867 
Moderate    Inter Info   
[21], [2], [56]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[57]
D0826
 
Interferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[58], [59], [60], [61]
D0827
 
Interferon beta-1b
 
NA
 
NA
Moderate    Inter Info   
[58], [59], [60], [61]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[2], [62]
D1106
 
Naltrexone
 
C20H23NO4
 
5360515 
Moderate    Inter Info   
[63]
D1239
 
Peginterferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[58], [59], [60], [61]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Moderate    Inter Info   
[65], [66]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[2], [67]
References
1 Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
4 Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
5 Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
6 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
7 Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
8 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
9 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
10 Product Information. Xigris (drotrecogin alfa). Lilly, Eli and Company, Indianapolis, IN.
11 Product Information. In-111 Zevalin (ibritumomab). IDEC Pharmaceuticals Corporation, San Diego, CA.
12 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
13 Cerner Multum, Inc. "Canadian Product Information.".
14 Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
15 Canadian Pharmacists Association.
16 EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
17 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
18 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
19 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
20 Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
21 Cerner Multum, Inc. "Australian Product Information.".
22 Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
23 Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
24 Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
25 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
26 Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
27 Bennett CL, Nebeker JR, Samore MH, et al "The Research on Adverse Drug Events and Reports (RADAR) project." JAMA 293 (2005): 2131-40. [PMID: 15870417]
28 Bennett CL, Schumock GT, Desai AA, et al "Thalidomide-associated deep vein thrombosis and pulmonary embolism." Am J Med 113 (2002): 603-6. [PMID: 12459408]
29 Cavo M, Zamagni E, Cellini C, et al. "Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy." Blood 100 (2002): 2272-3. [PMID: 12229885]
30 Escudier B, Lassau N, Leborgne S, Angevin E, Laplanche A "Thalidomide and venous thrombosis." Ann Intern Med 136 (2002): 711. [PMID: 11992318]
31 Figg WD, Arlen P, Gulley J, et al. "A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer." Semin Oncol 28(4 Suppl 15) (2001): 62-6. [PMID: 11685731]
32 Fine HA, Wen PY, Maher EA, et al. "Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas." J Clin Oncol 21 (2003): 2299-304. [PMID: 12805330]
33 Lee CK, Barlogie B, Munshi N, et al "DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma." J Clin Oncol 21 (2003): 2732-9. [PMID: 12860952]
34 Osman K, Comenzo R, Rajkumar SV "Deep venous thrombosis and thalidomide therapy for multiple myeloma." N Engl J Med 344 (2001): 1951-2. [PMID: 11419443]
35 Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
36 Rajkumar SV, Hayman S, Gertz MA, et al. "Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma." J Clin Oncol 20 (2002): 4319-23. [PMID: 12409330]
37 Urbauer E, Kaufmann H, Nosslinger T, Raderer M, Drach J "Thromboembolic events during treatment with thalidomide." Blood 99 (2002): 4247-8. [PMID: 12043695]
38 Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R "Thalidomide alone or with dexamethasone for previously untreated multiple myeloma." J Clin Oncol 21 (2003): 16-9. [PMID: 12506164]
39 Zangari M, Anaissie E, Barlogie B, et al "Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy." Blood 98 (2001): 1614-5. [PMID: 11520815]
40 Zangari M, Barlogie B, Anaissie E, et al "Deep vein thrombosis in patients with mutiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation." Br J Haematol 126 (2004): 715-21. [PMID: 15327525]
41 Zangari M, Siegel E, Barlogie B, et al "Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy." Blood 100 (2002): 1168-71. [PMID: 12149193]
42 Desai AA, Vogelzang NJ, Rini BI, Ansari R, Krauss S, Stadler WM "A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma." Cancer 95 (2002): 1629-36. [PMID: 12365009]
43 Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
44 Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab). GlaxoSmithKline, Research Triangle Park, NC.
45 Product Information. BexxarTherapy (tositumomab). GlaxoSmithKline Inc, Oakville, IA.
46 Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
47 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
48 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
49 European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
50 Gilead Sciences, Inc "About Remdesivir.".
51 US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
52 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
53 Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
54 Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
55 Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
56 Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
57 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
58 Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
59 Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
60 Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
61 Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
62 Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
63 Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
64 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
65 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
66 Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
67 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.